In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A strong ...

DexCom Inc. closed 34.58% short of its 52-week high of $132.26, which the company reached on May 17th.

DexCom, Inc. (DXCM), with a market cap of $33.9 billion, is a leading medical device company specializing in continuous ...

After this recent quarterly performance and the resultant increase in stock price, an important question arises: is DXCM ...

Shares of DexCom Inc. DXCM shed 1.11% to $84.11 Tuesday, on what proved to be an all-around mixed trading session for the ...

SAN DIEGO, May 13, 2025--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose biosensing, today announced the promotion of Jake Leach to president ...

We recently published a list of What Propelled These 10 Firms’ Double-Digit Gains? In this article, we are going to take a ...

DexCom's Q1 2025 earnings show strong growth potential, but cost pressures are impacting margins. Check out why I am lowering my rating on DXCM from buy to hold.

Noah Farabaugh, 33, was hiking on May 11 to prepare for a Grand Canyon rim-to-rim trek. He died from heatstroke. "Blows my ...

(RTTNews) - DexCom, Inc. (DXCM) announced Tuesday the promotion of Jacob Leach to president, in addition to his current role as chief operating officer, which he has held since 2022. With more ...

We recently published a list of These 10 Firms Soared Last Week, Here’s Why. In this article, we are going to take a look at ...